You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dasatinib

Showing 1 - 25 of 403
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Dasatinib
  • (no location specified)
Sep 20, 2023

Myeloma Multiple Trial in Chia (Dasatinib 100 MG)

Not yet recruiting
  • Myeloma Multiple
  • Dasatinib 100 MG
  • Chia, Cundinamarca, Colombia
    CAIMED
Jul 12, 2023

Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

Not yet recruiting
  • Lymphoblastic Leukemia
  • Dasatinib
  • Palo Alto, California
    Stanford University
Aug 14, 2023

Schizophrenia, Treatment Resistant Depression, Aging, Premature Trial in Saint Louis (Dasatinib + quercetin)

Not yet recruiting
  • Schizophrenia
  • +2 more
  • Dasatinib + quercetin
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 28, 2023

Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

Completed
  • Leukemia, Myelogenous, Chronic
  • CTTQ Dasatinib tablet
  • Sprycel Dasatinib tablet
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Dec 7, 2022

Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)

Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinomas
  • Tislelizumab + Dasatinib + Quercetin
  • surgery
  • (no location specified)
Feb 2, 2023

HIV Infection Primary Trial in Badalona (Dasatinib 70 mg, Placebo)

Not yet recruiting
  • HIV Infection Primary
  • Dasatinib 70 mg
  • Placebo
  • Badalona, Barcelona, Spain
    Hospital Universitari Germans Trias i Pujol
Mar 9, 2023

Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

Completed
  • Advanced Cancer
  • Dasatinib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 21, 2022

Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Dasatinib Pill
  • Ketoconazole Pill
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Nov 25, 2022

Among CP-CML Participants Initiating Dasatinib inReal Life

Completed
  • Chronic Myeloid Leukemia
  • Non-Interventional
  • Paris, France
    Local Institution
Jun 17, 2022

Biological Availability Trial in Hyderabad (Dasatinib ASD 100 mg, Dasatinib 140 MG [Sprycel])

Completed
  • Biological Availability
  • Dasatinib ASD 100 mg
  • Dasatinib 140 MG [Sprycel]
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Jun 28, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
Has Results
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

NAFLD, NASH With Fibrosis, Liver Fibrosis Trial (Dasatinib 100 MG + Quercetin (1250 MG), Placebo)

Not yet recruiting
  • NAFLD
  • +2 more
  • Dasatinib 100 MG + Quercetin (1250 MG)
  • Placebo
  • (no location specified)
Aug 16, 2022

Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole

Completed
  • Drug-drug Interaction Study
  • SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Nov 20, 2023

Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in Los Angeles (Dasatinib Anhydrous, Placebo Administration)

Withdrawn
  • Symptomatic COVID-19 Infection Laboratory-Confirmed
  • Dasatinib Anhydrous
  • Placebo Administration
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

Advanced Cancers Trial in Houston (Crizotinib, Dasatinib)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Dasatinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Dasatinib
  • Decitabine and Cedazuridine
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Dasatinib
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

Completed
  • Acute,Leukemia, Lymphoid
  • Dasatinib
  • +12 more
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 2, 2022

Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

Recruiting
  • Chronic Myeloid Leukemia in Chronic Phase
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Jul 26, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Dasatinib
  • +5 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 20, 2023

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Prostate Cancer Trial (Dasatinib)

Withdrawn
  • Prostate Cancer
  • Dasatinib
  • (no location specified)
Feb 23, 2022